Delivery Order SPE2DB20D2014-SPE2DB24FC36Q

Award Date 7/1/24
Potential Completion Date 7/2/24
Potential Value $3.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,740.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a diabetes treatment medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has a period of performance through May 14, 2025. The contract is not set aside for any particular business type. As a large...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a diabetes treatment medication, with a ceiling value of $2,448.81. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of May 29, 2025. The contract is not set-aside and is open to full and open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,088.36 with a ceiling of $1,088.36. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 27, 2025 and was awarded on June 26, 2025. This contract is not set-aside and is a Firm Fixed Price agreement. Amerisourcebergen Drug...
This federal contract award, valued at $1,794.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. This contract is not designated as a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Mounjaro 15 mg/0.5 ml pens. The delivery order contract, valued at $2,659.20, is a firm fixed-price agreement with a completion date of May 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,714.81 firm fixed-price delivery order is for the provision of Mounjaro 7.5 mg/0.5 ml pens, a medication used for the treatment of diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,765.25, is for the delivery of Mounjaro 2.5 mg/0.5 ml pens. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of September 10, 2024. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,448.81 firm fixed-price delivery order is for the supply of MOUNJARO 7.5 mg/0.5 ml pens, a diabetes medication. The award, which has an ultimate completion date of November 21, 2024, is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The $35,119.82 firm fixed-price delivery order has a period of performance through November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is a delivery order worth $2,176.72 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a diabetes medication. The contract has a firm fixed price and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC36Q
    Delivery Order

This federal contract award, valued at $3,892.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 2, 2024.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/30/24, 11:14 AM